Stage_I_seminoma_of_the_testis._Adjuvant_radiotherapy_or_surveillance?_Lately_the_role_of_radiotherapy_in_stage_I_seminoma_of_the_testis_has_been_questioned_by_some_authors_who_reported_on_a_"surveillance"_strategy_for_these_patients._Since_1980,_124_patients_with_seminoma_of_the_testis_have_been_referred_to_this_institution;_97_of_116_patients_analysed_presented_with_stage_I_disease_and_10_of_these_had_elevated_levels_of_beta_HCG._A_total_of_64_patients_were_given_radiotherapy_after_orchiectomy_and_33_entered_a_surveillance_protocol._After_a_median_follow-up_of_48_months,_3_patients_in_the_surveillance_group_relapsed_after_5,_13_and_49_months_and_2_of_the_irradiated_patients_did_so_after_25_and_33_months._Elevation_of_beta_HCG_was_not_significant_because_none_of_these_patients_showed_progression._A_low_rate_of_progression_and_excellent_survival_are_associated_with_standard_treatment_(orchiectomy_and_radiotherapy)_and_good_results_have_been_achieved_with_chemotherapy_in_cases_of_relapse._A_surveillance_policy_is_not_recommended_in_stage_I_seminoma_because_of_its_slower_growth_compared_with_non-seminomatous_germ_cell_tumours_(NSGCT),_the_absence_of_a_specific_tumour_marker,_the_10%_risk_of_occult_metastases_and_the_3-fold_higher_progression_rate_compared_with_irradiated_patients._We_suggest_the_use_of_a_reduced_dosage_and_radiation_field.